Dane Bedward

Dane Bedward possesses extensive experience in the biotechnology and healthcare sectors. Currently, Dane serves as a Member of the Board of Directors at PanTHERA CryoSolutions Inc. and the Chairman of the Board of Directors at Spiderwort Inc., which focuses on developing novel biomaterials for regenerative medicine. Additionally, Dane holds roles as Executive Fellow at Mistral Venture Partners, Entrepreneur In Residence at Invest Ottawa, and Principal at NBot Inc. From 1995 to 2011, Dane had a significant tenure at Genzyme Corporation, culminating in senior leadership roles including Senior Vice President of International Strategic Development and General Manager of Eurasia. Dane's earlier career featured positions at Nordion and Critikon, a Johnson & Johnson Company. Dane holds a Bachelor of Science, Honors in Biology from the University of Ottawa.